GSK-208136/016 (MeMuRu-OKA-016)

Study to assess immunogenicity and safety of two lots of GSK Biologicals' live attenuated measles-mumps-rubella-varicella vaccine, at two different titres, given as a single injection to healthy children with Biologicals' measles-mumps-rubella vaccine as control group
Combined Measles, Mumps, Rubella, Varicella Vaccine
208136/016 (MeMuRu-OKA-016)
Measles; Mumps; Rubella; Varicella
Phase 3
An annotated case report form is not available. A blank case report form will be provided. A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
October 2015